Health equity remains one of the most pressing challenges in the healthcare industry today. This session aims to delve into the multifaceted efforts and innovations that the biotech and pharmaceutical industries are implementing to address this urgent issue. Panelists will provide a comprehensive exploration of the strategies and initiatives that industry leaders are employing to bridge the health equity gap. Participants will gain insights into the latest advancements, collaborative efforts, and policy changes that are driving progress in this critical area.